Skip to content

Effects of Dexmedetomidine and Propofol on Pulmonary Mechanics

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02330120
Enrollment
64
Registered
2015-01-01
Start date
2011-01-31
Completion date
2015-08-31
Last updated
2015-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Respiratory Airway Resistance

Keywords

peak airway pressure, airway resistance, sedation, intensive care

Brief summary

The aim of this study is to compare the effects of dexmedetomidine and propofol on pulmonary mechanics in intensive care patients.

Detailed description

The aim of this study is to compare the effects propofol and dexmedetomidine on pulmonary mechanics. Sixty patients mechanically ventilated in intensive care unit are included in this study. Patients are divided into two random groups, Group P (propofol) and Group D (dexmedetomidine). Propofol infusion 0.5-2 mg/kg/h is given to Group P patients and dexmedetomidine infusion 0.2-0.7 mcg/kg/h is given to Group D patients for sedation. Initial blood gas analysis, airway resistance (cmH2O/L/sec), positive end-expiratory pressure (PEEP, cmH20), frequency (breath/min), tidal volume (mL/min), minute volume (mL), peak airway pressure (cmH20), compliance (mL/cmH20), endtidal CO2 (mmHg), SvO2 (%) values are recorded. This parameters are evaluated with Drager Evita 4 ventilator and recorded on 5th,15th,30th,45th ve 60th minutes . Sedation is observed using Riker and Ramsey Sedation-Agitation Scale. Compliance of patients to mechanical ventilation is observed and recorded. The primary outcome measures are airway resistance and peak airway pressure. Secondary outcome measure is sedation score.

Interventions

DRUGpropofol
DRUGdexmedetomidine

Sponsors

Cukurova University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* The patients mechanically ventilated in intensive care unit

Exclusion criteria

* Patients with contraindications for using propofol and dexmedetomidine

Design outcomes

Primary

MeasureTime frameDescription
airway resistance60 minutesairway resistans measured by Evita 4 ventilator flow sensor
peak airway pressure values60 minutespeak airway pressure values provide the methods used to Evita 4 ventilator flow sensor

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026